Impact of Hypoxia-Induced miR-210 on Pancreatic Cancer

Pancreatic cancer (PC) poses significant clinical challenges, with late-stage diagnosis and limited therapeutic options contributing to its dismal prognosis. A hallmark feature of PC is the presence of a profoundly hypoxic tumour microenvironment, resulting from various factors such as fibrotic stro...

Full description

Bibliographic Details
Main Authors: Mutian Lian, Maria Mortoglou, Pinar Uysal-Onganer
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Current Issues in Molecular Biology
Subjects:
Online Access:https://www.mdpi.com/1467-3045/45/12/611
_version_ 1797381598326292480
author Mutian Lian
Maria Mortoglou
Pinar Uysal-Onganer
author_facet Mutian Lian
Maria Mortoglou
Pinar Uysal-Onganer
author_sort Mutian Lian
collection DOAJ
description Pancreatic cancer (PC) poses significant clinical challenges, with late-stage diagnosis and limited therapeutic options contributing to its dismal prognosis. A hallmark feature of PC is the presence of a profoundly hypoxic tumour microenvironment, resulting from various factors such as fibrotic stroma, rapid tumour cell proliferation, and poor vascularization. Hypoxia plays a crucial role in promoting aggressive cancer behaviour, therapeutic resistance, and immunosuppression. Previous studies have explored the molecular mechanisms behind hypoxia-induced changes in PC, focusing on the role of hypoxia-inducible factors (HIFs). Among the myriad of molecules affected by hypoxia, microRNA-210 (miR-210) emerges as a central player. It is highly responsive to hypoxia and regulated by HIF-dependent and HIF-independent pathways. miR-210 influences critical cellular processes, including angiogenesis, metastasis, and apoptosis, all of which contribute to PC progression and resistance to treatment. Understanding these pathways provides insights into potential therapeutic targets. Furthermore, investigating the role of miR-210 and its regulation in hypoxia sheds light on the potential development of early diagnostic strategies, which are urgently needed to improve outcomes for PC patients. This review delves into the complexities of PC and introduces the roles of hypoxia and miR-210 in the progression of PC.
first_indexed 2024-03-08T20:53:43Z
format Article
id doaj.art-73243caabad541d6a85a1bb35d03656a
institution Directory Open Access Journal
issn 1467-3037
1467-3045
language English
last_indexed 2024-03-08T20:53:43Z
publishDate 2023-12-01
publisher MDPI AG
record_format Article
series Current Issues in Molecular Biology
spelling doaj.art-73243caabad541d6a85a1bb35d03656a2023-12-22T14:00:40ZengMDPI AGCurrent Issues in Molecular Biology1467-30371467-30452023-12-0145129778979210.3390/cimb45120611Impact of Hypoxia-Induced miR-210 on Pancreatic CancerMutian Lian0Maria Mortoglou1Pinar Uysal-Onganer2Cancer Mechanisms and Biomarkers Research Group, School of Life Sciences, University of Westminster, London W1W 6UW, UKCancer Mechanisms and Biomarkers Research Group, School of Life Sciences, University of Westminster, London W1W 6UW, UKCancer Mechanisms and Biomarkers Research Group, School of Life Sciences, University of Westminster, London W1W 6UW, UKPancreatic cancer (PC) poses significant clinical challenges, with late-stage diagnosis and limited therapeutic options contributing to its dismal prognosis. A hallmark feature of PC is the presence of a profoundly hypoxic tumour microenvironment, resulting from various factors such as fibrotic stroma, rapid tumour cell proliferation, and poor vascularization. Hypoxia plays a crucial role in promoting aggressive cancer behaviour, therapeutic resistance, and immunosuppression. Previous studies have explored the molecular mechanisms behind hypoxia-induced changes in PC, focusing on the role of hypoxia-inducible factors (HIFs). Among the myriad of molecules affected by hypoxia, microRNA-210 (miR-210) emerges as a central player. It is highly responsive to hypoxia and regulated by HIF-dependent and HIF-independent pathways. miR-210 influences critical cellular processes, including angiogenesis, metastasis, and apoptosis, all of which contribute to PC progression and resistance to treatment. Understanding these pathways provides insights into potential therapeutic targets. Furthermore, investigating the role of miR-210 and its regulation in hypoxia sheds light on the potential development of early diagnostic strategies, which are urgently needed to improve outcomes for PC patients. This review delves into the complexities of PC and introduces the roles of hypoxia and miR-210 in the progression of PC.https://www.mdpi.com/1467-3045/45/12/611pancreatic cancerhypoxiaHIF-1αmicroRNA-210
spellingShingle Mutian Lian
Maria Mortoglou
Pinar Uysal-Onganer
Impact of Hypoxia-Induced miR-210 on Pancreatic Cancer
Current Issues in Molecular Biology
pancreatic cancer
hypoxia
HIF-1α
microRNA-210
title Impact of Hypoxia-Induced miR-210 on Pancreatic Cancer
title_full Impact of Hypoxia-Induced miR-210 on Pancreatic Cancer
title_fullStr Impact of Hypoxia-Induced miR-210 on Pancreatic Cancer
title_full_unstemmed Impact of Hypoxia-Induced miR-210 on Pancreatic Cancer
title_short Impact of Hypoxia-Induced miR-210 on Pancreatic Cancer
title_sort impact of hypoxia induced mir 210 on pancreatic cancer
topic pancreatic cancer
hypoxia
HIF-1α
microRNA-210
url https://www.mdpi.com/1467-3045/45/12/611
work_keys_str_mv AT mutianlian impactofhypoxiainducedmir210onpancreaticcancer
AT mariamortoglou impactofhypoxiainducedmir210onpancreaticcancer
AT pinaruysalonganer impactofhypoxiainducedmir210onpancreaticcancer